Advanced Search:
Equity Index

AZT.OL - ARCTICZYMES TECHNO

kr23.75  -1.5 (-5.94%)

Updated: 08:24 May 8, 2024 EST

Next Session's AI Forecast

97.92%

Avg. Accuracy (AI)

kr25.09

Next Week's AI Forecast

100%

Trend's Accuracy (AI)

kr23.67

ARCTICZYMES TECHNO's Position Within the Biotechnology Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

ARCTICZYMES TECHNO - HISTORICAL DATA 6M

  • Last price

    kr23.75

  • Daily change

    kr-1.5

  • Previous Close

    kr25.25

  • Last Updated

    08:24 May 8, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-2.7 -0.9 -0.4 -0.43 -0.17

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
2.7 1.72 2.42 2.21 2.37

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
0% 0% 0% 0%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
24.82 -3.46% 25.71 -5.23% 27.13 -18.53% 33.3

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.15 38.65 0.35 13.04

ARCTICZYMES TECHNO Technical Analysis News

ARCTICZYMES TECHNO

Sykehusveien 23
SIVA Innovation Centre PO Box 6463
Tromsø 9294
Norway
47 77 64 89 00
https://arcticzymes.com

Sectors: Healthcare
Industry: Biotechnology
Description

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

Corporate Governance

ArcticZymes Technologies ASA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

ARCTICZYMES TECHNO'S HOLDERS RANK

List of holders with stock participation in ARCTICZYMES TECHNO.

Holder Rank Holder Shares Date Reported % Out Value